Taub, Daniel G. http://orcid.org/0000-0003-0363-6031
Jiang, Qiufen
Pietrafesa, Francesca
Su, Junfeng http://orcid.org/0000-0002-3415-5655
Carroll, Aloe http://orcid.org/0009-0009-2775-9651
Greene, Caitlin
Blanchard, Michael R.
Jain, Aakanksha
El-Rifai, Mahmoud
Callen, Alexis
Yager, Katherine
Chung, Clara
He, Zhigang http://orcid.org/0000-0001-6080-6880
Chen, Chinfei http://orcid.org/0000-0002-6486-3097
Woolf, Clifford J. http://orcid.org/0000-0002-6636-3897
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 AT011447)
Article History
Received: 13 June 2023
Accepted: 1 February 2024
First Online: 12 February 2024
Competing interests
: C.J.W is a founder of Nocion Therapeutics, Quralis, and Blackbox Bio. Z.H. is a founder of Myrobalan Therapeutics and Rugen, and an advisor of Axonis. The remaining authors declare no competing interests.